Description: Avantor, Inc. develops, customizes, manufactures, and supplies products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, and process chromatography resins and columns, as well as analytical sample prep, education, and microbiology and clinical trial kits. Its equipment and instrumentation products comprise filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and environment supplies. The company also provides onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Home Page: www.avantorsciences.com
AVTR Technical Analysis
Radnor Corporate Center
Radnor,
PA
19087
United States
Phone:
610 386 1700
Officers
Name | Title |
---|---|
Mr. Michael Stubblefield | Pres, CEO & Director |
Mr. Thomas A. Szlosek | Exec. VP & CFO |
Dr. Gerard Brophy Ph.D. | Exec. VP of Biopharma Production |
Mr. Frederic Vanderhaegen | Exec. VP of Europe |
Ms. Sheri Lewis | Exec. VP of Global Supply Chain |
Mr. Steven W. Eck | Sr. VP, Corp. Controller & Chief Accounting Officer |
Mr. Michael Wondrasch | Exec. VP & Chief Information Officer |
Mr. Tommy J. Thomas CPA | VP of Investor Relations |
Mr. Justin M. Miller Esq. | Exec. VP, Gen. Counsel & Sec. |
Ms. Allison K. Hosak | Sr. VP of Global Communications & Brand |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 14.7275 |
---|---|
Trailing PE: | 21.5208 |
Price-to-Book MRQ: | 3.1086 |
Price-to-Sales TTM: | 1.8869 |
IPO Date: | 2019-05-17 |
Fiscal Year End: | December |
Full Time Employees: | 13500 |